Dr. Craig Moskowitz, MD
Claim this profileUniversity of Miami
Expert in Cancer
Studies Hodgkin's Lymphoma
12 reported clinical trials
23 drugs studied
Area of expertise
1Cancer
Global LeaderStage II
Stage I
Stage IV
2Hodgkin's Lymphoma
Stage II
Stage I
Stage IV
Affiliated Hospitals
Clinical Trials Craig Moskowitz, MD is currently running
SGN-35T
for Lymphoma
This trial is testing a new drug in adults with certain types of lymphoma that haven't responded to other treatments. The drug works by targeting a protein on cancer cells and delivering a substance that kills them. This drug has shown high selectivity against specific cancer cells and has been approved for treating lymphoma patients.
Recruiting1 award Phase 110 criteria
SGN-35C
for Lymphoma
This clinical trial is studying lymphoma. Lymphoma is a cancer that starts in the blood cells that fight infection. There are several types of lymphoma. This study will enroll people who have classical Hodgkin lymphoma (cHL), peripheral T cell lymphoma (PTCL), or diffuse large B cell lymphoma (DLBCL). This clinical trial uses a drug called PF-08046044/SGN-35C . The study drug is in testing and has not been approved for sale. This is the first time SGN -35C will be used in people. This study will test the safety of SGN-35C in participants with lymphoma. It will also study the side effects of this drug. A side effect is anything a drug does to the body besides treating the disease. This study will have three parts. Parts A and B of the study will find out the best dose and dosing schedule for SGN-35C. Part C will use the dose found in parts A and B to find out how safe SGN-35C is and if it works to treat select lymphomas.
Recruiting1 award Phase 14 criteria
More about Craig Moskowitz, MD
Clinical Trial Related1 year of experience running clinical trials · Led 12 trials as a Principal Investigator · 8 Active Clinical TrialsTreatments Craig Moskowitz, MD has experience with
- Rituximab
- Pembrolizumab
- Brentuximab Vedotin
- Dacarbazine
- Mosunetuzumab
- LIFE-L Home-Based Exercise Program
Breakdown of trials Craig Moskowitz, MD has run
Hodgkin's Lymphoma
Non-Hodgkin's Lymphoma
Diffuse Large B-Cell Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Craig Moskowitz, MD specialize in?
Craig Moskowitz, MD focuses on Cancer and Hodgkin's Lymphoma. In particular, much of their work with Cancer has involved Stage II patients, or patients who are Stage I.
Is Craig Moskowitz, MD currently recruiting for clinical trials?
Yes, Craig Moskowitz, MD is currently recruiting for 8 clinical trials in Miami Florida. If you're interested in participating, you should apply.
Are there any treatments that Craig Moskowitz, MD has studied deeply?
Yes, Craig Moskowitz, MD has studied treatments such as Rituximab, Pembrolizumab, Brentuximab Vedotin.
What is the best way to schedule an appointment with Craig Moskowitz, MD?
Apply for one of the trials that Craig Moskowitz, MD is conducting.
What is the office address of Craig Moskowitz, MD?
The office of Craig Moskowitz, MD is located at: University of Miami, Miami, Florida 33136 United States. This is the address for their practice at the University of Miami.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.